As America goes to the polls and markets don't really know which way to turn, online titan Amazon.com Inc (NASDAQ:AMZN) is in focus.
Shares in the Jeff Bezos group shed 0.33% to $1,622.38 in pre-market deals, having closed yesterday over 2% lower.
Is there any news? Some — reportedly. Amazon is to split its new headquarters, dubbed HQ2, between two cities, a year after the plan was first mooted. It's because the firm can't find a single, suitable site.
Cities have naturally been keen to attract the megacompany, as it will mean thousands of jobs and millions in tax revenues.
Crystal City, a neighborhood in Northern Virginia, is thought to be a frontrunner due to its closeness to Washington, DC.
In other pre-market news, Activision Blizzard Inc (NASDAQ:ATVI) saw shares swirl up 0.48% to $64.65 before the New York bell, having slumped 6.74% yesterday.
It came reportedly as angry video gamers took to social media to criticize the group's new mobile game that they claimed did not live up to the 'storied franchise'.
Reportedly, there's even a petition on change.org to cancel the launch that has over 31,000 supporters.
Elsewhere, in pre-market news, Mylan NV (NASDAQ:MYL) added over 8% in before the bell deals to $34.06.
It came as the generic and specialty pharmaceuticals company, which makes EpiPen, beat earnings per share (EPS) estimates in its latest quarterly results, but missed on revenue.
The firm posted $1.25 a share, while analysts had estimated $1.19 a share.
But the group reported revenue of $2.86 billion in revenue, after estimates of $2.91 billion.
Meanwhile, CVS Health Corp (NYSE:CVS) saw shares zip up 3.13% to $76 before the New York bell, the firm having nudged up 0.82% yesterday, after it reported a beat on third-quarter earnings.
Adjusted earnings per share (EPS) came in at $1.73 versus the $1.71 per share, which had been expected. Revenue was $47.3 billion against Wall Street scribes estimates of $47.2 billion.